Oxford Global, Hilton San Diego Mission Valley, 901 Camino del Rio South, San Diego, CA, 92108, USA,
17 - 18 March 2020
Over 300 delegates from the inhalation, formulation and drug delivery industry representing global pharmaceutical organisations, leading biotech companies and internationally renowned academic & research institutions. Over 20 presentations and case studies focussing on the emerging therapies and key issues in inhalation and respiratory drug delivery as well as the latest developments in medical devices and digital health products. Including 2 interactive streams: Development & Formulation of Inhaled Therapies Inhalation Devices & Analytics *View Agenda: https://bit.ly/33Tqvwh This event is co-located with the 3rd Annual Formulation & Drug Delivery USA Congress For more information, please contact e.hawkings@oxfordglobal.co.uk Go Social: Join our Formulation & Drug Delivery Network on LinkedIn, follow us on Twitter @FDDCongress & join the conversation at #FDDUS19
*2020 Live Webinar*
‘The Design And Development Of A Connected Inhalation System To Help With Monitoring And Patient Adherence’ Hosted by Paul Upham, Head, Smart Devices, Genentech Wed, Jan 15, 2020 4:30 PM - 5:30 PM GMT Register for Free: https://bit.ly/2kK3BqB
|
|
|
Invited Speakers:
|
|
Christy Cappelletti, Director, Clinical Development, AstraZeneca Yaping Zhu, Executive Director, Device Development & Inhalation Development, Sandoz George Cusatis, Associate Director, Device & Digital Health, Merck Samir Shah, Associate Director, Respiratory and Combination Regulatory Affairs, Teva Paul Upham, Head, Smart Devices, Genentech Larry Brown, Chief Scientific Officer & Executive Vice President, Noveome Carlos Schuler, Chief Operating and Technical Officer, InCarda Therapeutics Stephen Pham, Vice President Product Development, Avalyn Pharma
|
|